Dr. Toni K Choueiri M.D.
Oncologist | Medical Oncology
Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH, 44195About
Dr. Toni K. Choueiri is Associate Professor of Medicine at Harvard Medical School and Attending Physician in the Division of Solid Tumor Oncology at Dana-Farber Cancer Institute (DFCI). He also serves ...
Education and Training
Universite Saint Joseph MD
Saint Joseph University of Beirut
Temple University School of Medicine 2000
Saint Joseph University Faculte of Medicine
University of St. Andrews School of Medicine 2000
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- 2004
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2007
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics.
- The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma.
- Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy.
- Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma.
- Differential expression of caveolin-1 in renal neoplasms.
- Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell
- Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.
- Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumors.
- Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
- The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
- Recent advances in the systemic treatment of metastatic papillary renal cancer.
- Optimizing recent advances in metastatic renal cell carcinoma.
- Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis.
- Treatment selection for patients with metastatic renal cell carcinoma.
- Non-clear cell renal cancer: features and medical management.
Clinical Trials
Treatments
- Bladder Cancer
- Kidney Cancer
Dr. Toni K Choueiri M.D.'s Practice location
Dr. Toni K Choueiri M.D.'s reviews
Write ReviewPatient Experience with Dr. Choueiri
Recommended Articles
- Don't Call Them Just Survivors; They Are "Overcomers"
It’s common to throw the word "survivor" thrown around when referring to people who have battled illnesses and diseases. However, a group in San Antonio prefers to refer to themselves as Overcomers.Genny's storyWhen Genny Small was diagnosed with breast cancer, she could not believe it. She...
- What Specialist Treats Ovarian Cancer?
Ovarian cancer is very difficult to diagnose, and many women feel mild symptoms or no symptoms at all in the early stages of the disease. A whole team of doctors can help with diagnosing and treating ovarian cancer, including the family doctor, gynecologist, and oncologist. Some women have that luck...
- Nodular Melanoma Symptoms
What is nodular melanoma?Nodular melanoma is one of the five subgroups of melanoma. It usually develops in the cells of the skin that produce the pigment called melanin, which gives the skin its color. Approximately 15 percent of melanoma cases are nodular melanoma and is the most aggressive...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Comparative Value of PARP Inhibitors is Lacking, According to ICER Report
The Institute for Clinical and Economic Review, also known as ICER, is a non-profit organization that analyzes the value of new medical tests, treatments, and drugs approved by the U.S. Food and Drug Administration (FDA). The goal of ICER is to use the value of these innovations and develop reports...
- Talcum Powder and Ovarian Cancer: The Facts
When watching TV, it’s hard not to notice those commercials urging women to “call this number if…!” It’s difficult to know if these are based on fact or are just alarmist reactions to poorly researched issues. TV commercials are hardly the best place to get health information. Yet this is...
Nearby Providers
- Dr. Susan B. LeGrand MD9500 Euclid Avenue Cleveland Ohio 44195
- Mellar P. Davis9500 Euclid Avenue Cleveland Ohio 44195
- Dr. Saby George MD9500 Euclid Avenue Cleveland OH 44195
- Dr. Alberto Montero MD9500 Euclid Ave Cleveland OH 44195
- Dr. Kenneth S Weiss MD9500 Euclid Ave Cleveland OH 44195
- Dr. Lisa Ostrosky Sproat MD, MSWCleveland Clinic 9500 Euclid Ave Cleveland OH 44195